WASHINGTON, D.C. — Senator Robert F. Kennedy Jr. announced a $100 million “Vaccine Injury Initiative” on Tuesday, urging the Department of Health and Human Services to launch a dedicated research program on rare adverse events, a move that has drawn cautious interest from vaccine‑safety experts.

The proposal calls for a multi‑disciplinary task

Key Takeaways

• Volatility in the Health & Medicine market is likely to continue near-term.
• Stakeholders should prepare for shifts in policy and demand.
• Cross-border coordination remains critical.

As the situation evolves, decision-makers must remain agile. Continued monitoring and data-driven insights will determine who leads the next phase.